Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by 18tee20on Dec 17, 2008 9:35pm
364 Views
Post# 15653165

RE: LSDF award

RE: LSDF award

Actually, if you read the release again, when they discuss ecoli vaccine it sounds more like they are addressing an existing vacinne or vacinnes.  Phase 1 clinical trials are only mentioned for the lovely syphilis and herpes medicine....

"-- Develop an E. coli vaccine for cattle (a joint effort of WSU, UW and the University of Idaho). Researchers will test and identify the best candidate for a vaccine that would reduce the level of E. Coli O157 in cattle to a level that would prevent transmission to humans via meat or waste.

-- Develop a herpes vaccine (a joint effort of the Hutchinson Center, IDRI and UW). Researchers will test and select the most effective vaccine formulations for phase 1 clinical trials.

-- Develop a syphilis vaccine (a joint effort of UW, IDRI and the University of Victoria). Researchers will test, evaluate and select the best vaccine formulation to complete preclinical development and then test in phase 1 clinical trials."

Bullboard Posts